Why Moderna Shares Jumped 6% on Tuesday

Benzinga2022-03-23

Moderna Inc shares traded higher Tuesday after the company announced two new vaccine candidate developments.

Moderna will launch a respiratory combination vaccine program to target three of the most significant viruses causing respiratory disease in older adults. The new combination respiratory vaccine candidate, mRNA-1230, would act as an annual booster targeting SARS-CoV-2 virus, influenza virus and respiratory syncytial virus.

Moderna also introduced a program to develop vaccine candidate mRNA-1287 against endemic human coronaviruses. Four human coronaviruses are endemic globally, accounting for approximately 10% to 30% of upper respiratory tract infections in adults.

MRNA 52-Week Range:$117.34 - $497.49

Moderna Shares closed higher 6.47% at $186.72.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • 339742f5
    2022-03-23
    339742f5
    Should i buy moderna share?
  • KeN3
    2022-03-23
    KeN3
    Prices down for the others though
  • yeo
    2022-03-23
    yeo
    Stay out medical. Short squeeze 
  • Thomas9413
    2022-03-23
    Thomas9413
    Great 
  • ALIBINHASSAN
    2022-03-23
    ALIBINHASSAN
    I love Moderna
  • Bull_Horn
    2022-03-23
    Bull_Horn
    👍
Leave a comment
13